Skip to content
healthcare.dev

Imatinib Mesylate

NDC 68001-622, Imatinib Mesylate, tablet, film coated, from BluePoint Laboratories.

Product NDC
68001-622
Status
Listed
Labeler
BluePoint Laboratories
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212773
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68001-622 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE100 mg/1

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
68001-622-056800106220590 TABLET, FILM COATED in 1 BOTTLE (68001-622-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c0611fc0-b217-4988-acd4-b8c629ce489b
  • NADAC price for package 68001062205

    GET /v1/drugs/nadac/68001062205

Use it

Look up 68001-622 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68001-622 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68001-622. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.